Other Announcements1 Min Read InvestyWise NewsonOctober 23, 2025 Bharat Forge Selected as L1 Bidder for Army Carbine Supply Bharat Forge Limited (BFL) has been identified as the L1 bidder for the Indian Army’s Close Quarters Battle Carbine requirement. The…
Company Update2 Min Read InvestyWise NewsonOctober 23, 2025 Premier Energies Acquires 51% Stake in Transcon Ind Limited for Transformer Manufacturing Premier Energies Limited has approved the acquisition of a 51% stake in M/s Transcon Ind Limited, a company involved in the manufacturing of…
Company Update1 Min Read InvestyWise NewsonOctober 23, 2025 Laurus Labs Strong H1 Performance with 33% Revenue Growth Laurus Labs announced strong H1 FY26 results, with revenue reaching ₹3,223 Cr, a 33% increase. EBITDA stood at ₹818 Cr, with a margin of…
Board Meeting1 Min Read InvestyWise NewsonOctober 23, 2025 Laurus Labs Interim Dividend Declared; Revenue Jumps in Q2 2026 Laurus Labs has reported a robust financial performance for Q2 2026, with revenue from operations reaching ₹1,653.47 crore. The Board has…
Company Update2 Min Read InvestyWise NewsonOctober 23, 2025 ICICI Prudential Earnings Call Transcript for Quarter Ended September 30, 2025 ICICI Prudential Life Insurance announced the earnings call transcript for the quarter and half year ended September 30, 2025. Total premium…
Board Meeting1 Min Read InvestyWise NewsonOctober 23, 2025 Bank of Baroda Board to Approve Q2 Financial Results October 31, 2025 Bank of Baroda will hold a board meeting on Friday, October 31, 2025, to consider and approve the Un-audited (Reviewed) Standalone &…
Company Update1 Min Read InvestyWise NewsonOctober 23, 2025 CEAT Limited Q2 FY26 Results Earnings Call Transcript Available CEAT Limited has announced the availability of the transcript for its Q2 FY26 earnings call. The earnings call, which discussed the unaudited…
Company Results1 Min Read InvestyWise NewsonOctober 23, 2025 Laurus Labs Interim Dividend Declared as Q2 Results Approved Laurus Labs’ Board approved the unaudited financial results for Q2 2025, ending September 30, 2025. A dividend of ₹0.80 per share was…
Board Meeting1 Min Read InvestyWise NewsonOctober 23, 2025 Indegene Limited Board to Consider Quarterly Results on October 30, 2025 Indegene Limited has announced a board meeting scheduled for October 30, 2025, to review and approve the unaudited consolidated and standalone…
Company Update1 Min Read InvestyWise NewsonOctober 23, 2025 Caplin Point USFDA Approves Nicardipine Injection & Acquires ANDAs Caplin Point Laboratories has received USFDA approval for its subsidiary, Caplin Steriles Limited, for Nicardipine Hydrochloride Injection.…